Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
The current price of Eli Lilly And Co in the market is $885.07, with a 24-hour trading volume of $3.21B. The asset's market cap is $790.4B, after moving -3.55% in the last day.
Tokenized Eli Lilly And Co is trading at $888.03, with a tokenized market cap of $4.9M and a 24-hour trading volume of $2.21M. The tokenized asset has moved -3.33% in the past 24 hours.